Overview
- The Trump administration’s January suspension of foreign aid shuttered USAID and wiped out the $4 billion PEPFAR pledge that underpinned global HIV prevention and treatment
- UNAIDS reports that the funding freeze has already destabilized supply chains, closed clinics, left thousands of health workers unemployed and stalled HIV testing in multiple countries
- If the US commitment is not restored, the UN projects more than four million additional AIDS-related deaths and six million new HIV infections by 2029
- Low- and middle-income countries have boosted HIV budgets by about 8 percent but these increases fall far short of filling the void left by US aid
- The FDA’s approval of the twice-yearly HIV prevention injection Yeztugo offers hope, but its rollout is imperiled by funding gaps, high prices and delayed access to generics